GGrantIndex
← Leaderboards

Michael F Grunebaum

Columbia University Health Sciences

$5,425,154
Attributed
$5,425,154
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $607K · FY200622
$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$5,425,154 · 3

By mechanism

R01$4,541,009 · 2
K23$884,145 · 1

Top collaborators

No co-investigators on record.

Most similar at Columbia University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Suicidal Behavior

  • Robert J. Ursano · Henry M. Jackson Fdn For The Adv Mil/Med$42,497,358
  • David A. Brent · University Of Pittsburgh At Pittsburgh$30,087,618
  • Robert A Hummer · Univ Of North Carolina Chapel Hill$28,336,705
  • Joseph J Mann · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc$27,891,616
  • Boris Birmaher · University Of Pittsburgh At Pittsburgh$25,355,585
  • Murray B. Stein · University Of California, San Diego$22,696,471

Research focus

Suicidal BehaviorSuicide AttemptSuicidePharmaceutical PreparationsSuicidalSuicide PreventionDouble-Blind MethodAntidepressive AgentsClinical TrialsFeeling SuicidalSuicidal RiskDepressed MoodMental DepressionHigh RiskRandomizedMajor Depressive DisorderResponseMoodsDepression And SuicideCause Of DeathBupropionSamplingChronicAnesthetics

Grant awards (14)

IM Ketamine for rapid reduction of suicidal thoughts in high-risk emergency room patients: a midazolam-controlled trial$575,915
R01 · FY2022 · MH · contact PI
IM Ketamine for rapid reduction of suicidal thoughts in high-risk emergency room patients: a midazolam-controlled trial$575,727
R01 · FY2021 · MH · contact PI
IM Ketamine for rapid reduction of suicidal thoughts in high-risk emergency room patients: a midazolam-controlled trial$607,024
R01 · FY2020 · MH · contact PI
Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in Depression$586,167
R01 · FY2016 · MH · contact PI
Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in Depression$501,596
R01 · FY2015 · MH · contact PI
Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in Depression$77,427
R01 · FY2015 · MH · contact PI
Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in Depression$527,065
R01 · FY2014 · MH · contact PI
Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in Depression$505,984
R01 · FY2013 · MH · contact PI
Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in Depression$584,104
R01 · FY2012 · MH · contact PI
Paroxetine/Bupropion in Suicide Attempters/Ideators with Major Depression$176,861
K23 · FY2010 · MH · contact PI
Paroxetine/Bupropion in Suicide Attempters/Ideators with Major Depression$176,861
K23 · FY2009 · MH · contact PI
Fluoxetine Versus Bupropion in Suicide Attempters With Major Depressive Disorder$176,861
K23 · FY2008 · MH · contact PI
Fluoxetine Versus Bupropion in Suicide Attempters With Major Depressive Disorder$176,861
K23 · FY2007 · MH · contact PI
Fluoxetine/Bupropion Suicide Attempters Major Depressive$176,701
K23 · FY2006 · MH · contact PI